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Abstract 
The importance of uterus is the process of reproduction and conservation of the human in the earth as well as  
motherhood is the dream of every woman to give her sense of femininity and importance in this presence. The 
purposes of this study was to shed light on the importance of MRI and its diagnostic value for the different types 
of uterine masses in symptomatic patients. This study was conducted at Saudi German Hospital in the period 
(2015-2016). Data were retrospectively collected from 100 patients who had come to the Radiology Department 
from obstetrics and gynecology departments with different  symptoms,  age range (19-70) years and mean age 
(2.40 ) years. All patients were subjected to Magnetic Resonance Imaging. Out of 100 patient; (92) were 
diagnosed by MRI with different uterine masses while 8 cases showed normal result despite the presence of 
symptoms. Uterine fibroid (35%) was the most common pathologic findings, followed by cervical carcinoma 
(22%), endometrial carcinoma (14%), endometriosis (11%) and adenomyosis (10%).  Uterine fibroids (27 out of 
35)patient; was more frequent among patients  in the age group of (20-49)y. Cervical carcinoma (12out of 22) 
cases; was more common among the  age group of (20-49)year  too. Endometrial carcinoma (7out of 14) cases 
was frequent  among  the age group of (>60 )year. Endometriosis and Adenomyosis were common in the age 
group of (20-49) year.  The study results reflect that Magnetic resonance imaging (MRI) is an excellent method 
for diagnosing and evaluating uterine masses. 
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1. Introduction  
Uterine masses are tissue enlargements of the uterus. They are either benign or malignant. Benign tumor is a 
mass of cells that do not  invade neighboring tissue, whereas malignant tumors most of times can metastasize 
and invade tissue nearby [1].      
The most common benign uterine tumors are fibroids with incidence of 217-3745 cases per 100 000 women-
years and prevalence of 4.5-68.6% [2].  heavy menstrual bleeding is the most common symptom, which may 
lead to anaemia and painful periods[3,4]. also fibroids may cause  infertility [5,6].   
The most common malignant uterine tumor  in the United States is endometrial carcinoma. The incidence of 
endometrial carcinoma is estimated to increase by 1–2% yearly [7].      
Cervical cancer is the third most common malignancy in women worldwide [8].   It is one of the most 
successfully treatable cancers when discovered early[9]. According to American Cancer Society estimation for 
year 2018;  about 13,240 new cases of invasive cervical cancer will be diagnosed and about 4,170 women will 
die from cervical cancer [9].   
Computed tomography (CT) cannot  differentiate between fibroids and uterine sarcomas, thus is not the choice 
for the characterization of pelvic masses[9,10]. It is limited in the pelvis by a lack of soft-tissue contrast [11].   
Ultrasound cannot accurately differentiate between Uterine leiomyoma and   leiomyosarcoma [12].        
Magnetic Resonance Imaging (MRI) is a noninvasive and nonionizing imaging method that uses a magnetic 
field and radio waves to produce detailed images. previous studies concluded that Magnetic Resonance Imaging 
(MRI)  is the most useful imaging method to evaluate uterine masses  [11,13,14]. 
The aim of this work was to elicit the diagnostic value of MRI in evaluation of uterine masses in symptomatic 
female patients.  
2. Material and methods 
This retrospective study was conducted at Saudi German Hospital in the period (2015-2016). Data were 
collected from the records (PACS) for 100 patients who had come to the Radiology Department from obstetrics 
and gynecology departments with different symptoms such as Heavy menstrual bleeding, Dysmenorrhea, Back 
pain, Infertility, Post-menopausal bleeding and other symptoms,  with age range  (19-70 ) years and mean age of 
(2.40 )years. All patients were subjected to magnetic resonance imaging using 3 Tesla MRI system (Magnetom  
verio, Siemens Medical systems, Erlangen, Germany).   
2.1 Statistics  
Magnetic resonance imaging findings of uterine masses were collected with demographic data including patient’ 
age and symptoms. SPSS version 19 was used for data analysis and the results  illustrated accordingly. 
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3. Result  
The pelvis is an ideal area for MRI imaging because of high proton density, good inherent contrast to noise 
ratio. Hence, MR Imaging  was the best and most appropriate way to diagnose uterine masses. 
In this study the total number of female patients was 100 with 100  uetrine tumor. Patients came with different 
symptoms and all patients underwent magnetic resonance imaging. 
(Table 1) reflects the distribution of age group  for 100 female patients, the age group of  (20-49) years  
reflected  high frequency compared to the other age groups.                                                                                                                                   
Heavy menstrual bleeding was the most common symptoms among the study group(Table2).                                     
Pathologic  findings of female uterus revealed  uterine fibroids  were  the most common pathology among the 
study group. (Table 3 )    
There was a strong correlation between patient age and uterine mass incidence.  (Table 4) 
4. Discussion 
The current study reflects the ability of MRI technology in the diagnosis and classification of various uterine 
masses in a symptomatic patients. 
After analyzing patient’s data, I fully realized that the diagnosis and characterization of uterine masses by 
magnetic resonance technology is one of the best ways to produce results that are impressive and reliable.  
Of 100 patient;  (92) were diagnosed with different uterine masses and only (8 patient) diagnosed as normal 
(Tables 3,4). 
(Table and Figure 1)  reflects the age distribution  by using the class intervals and frequencies for the study 
group. Age group of  (20-49)y represented  high frequency (66%) followed by age group of  (50-60) with 
frequency of (22%) . <60 were (10%)  and the least was the age group of (<20) with frequency of( 2%) only. 
From the collected data, patients were found to have different symptoms as shown on (Table2). Heavy 
menstrual bleeding (27 patients) was one of the most common symptoms among patients followed by post 
menopausal bleeding (21 patients), dysmenorrhea and back pain presented in (10 patients),  pelvic pain (7 
patient), Increased vaginal discharge (4 patients), and (3 patient) for each of Severe menstrual cramps- 
prolonged menstrual bleeding and frequent urination. Spotting between periods and Abnormal vaginal discharge 
were the least (one patient each). 
Uterine fibroids were  the most common pathology among the study group, they were in 35% (35patient), this 
result is in agreement with (Radmila S. and his colleagues -2016) [15], followed by cervical carcinoma 22% 
(22patient), endometrial carcinoma 14% (14patient), Endometriosis 11% (11patient) and adenomyosis 10% (10 
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patient) (Table3 and figure3 ).   
The current study shows that there is a relationship between the ages of patients and the incidence of uterine 
tumors (Table4). The incidence of uterine fibroids (Total cases=35) in the age group of (20-49)y  was high 
(27patient), this result copes with (Radmila S. and his colleagues-2016) who stated (Myomas  are the most 
common benign neoplasm of the reproductive organs in women of reproductive age) [15].  Followed by the age 
group of (50-60)y (7patient), and only (one patient) found with uterine fibroids  (<20 )y . 
In cervical carcinoma (Total cases=22); the age group of (20-49) y, was the more affected group (12patient) 
followed by the age group of (50-60)y, (7patient),  this result was in agreement with (SEER cancer statistics-
2016) who reported;(From 2006-2012, the median age of cervical cancer diagnosis was 49 but still older women 
remain at risk) [16]. There were (3patient ) in the age group of (>60 )y. No patient among the  age group of 
(<20)y founds   to have cervical cancer, this result was in accordance with (American Cancer Society-2016) 
who reported; (Cervical cancer is rare in women younger than age 20) [17]. 
The incidence of endometrial carcinoma (Total cases= 14) was more common among  the age group of  (>60 )y  
(7patient), this result coincides with  (American Cancer Society-2018) who reported; (Endometrial cancer 
affects mainly postmenopausal women and the  average age is 60) [18]. Followed by the age group of (50-60)y 
(6patient).  
The incidence of endometrial carcinoma in the group study of (20-49)y, was only (one patient ), this result 
agrees with (American Cancer Society-2018 ) who reported; (endometrial cancer is uncommon in women under 
the age of 45) [18]. 
Endometriosis (Total cases=11) was more common among the age group of (20-49)y (10 patient), whereas the 
incidence of endometriosis in the age group of (<20) y, was only (One patient). 
Adenomyosis (Total cases=10) was common among the age group of (20-49)years (9 patient), and (One patient)  
for the age group of (50-60)y. 
Endometriosis and adenomyosis are characterized by the presence of endometrial tissue in other places rather 
than normal ones[19]. 
The results of this study (Table 4) showed that the incidence of these two diseases was common among the age 
group of (20-49)y (reproductive age), this result was in agreement with (Parente Barbosa C and his colleagues -
2011) who stated that; (Endometriosis and adenomyosis are considered to be a problem mainly before 
menopause) [20].  
Although from my result I had an incidence of adenomyosis-one patient- among the age group of (50-60)y 
(beyond reproductive age) 
It is noted that I have agreed with all results of authors regarding the use of magnetic resonance imaging in the 
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diagnosis  of various uterine masses. which confirms the effectiveness and  reliability of this wonderful and 
exciting technology.  
5. Tables   
Table 1: Distribution of Age Group  for 100 Patients 
 Frequency Percent Valid Percent Cumulative Percent 
Valid <20 2 2.0 2.0 2.0 
20-49 66 66.0 66.0 68.0 
50-60 22 22.0 22.0 90.0 
>60 10 10.0 10.0 100.0 
Total 100 100.0 100.0  
 
Table 2:  Symptoms and Signs of Uterine Masses  in 100 Patients 
 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 
Heavy menstrual bleeding 27 27.0 27.0 27.0 
Post menopausal bleeding 21 21.0 21.0 48.0 
Dysmenorrhea 10 10.0 10.0 58.0 
Constipation 2 2.0 2.0 60.0 
Back pain 10 10.0 10.0 70.0 
Infertility 6 6.0 6.0 76.0 
Severe menstrual cramps 3 3.0 3.0 79.0 
Spotting between periods 1 1.0 1.0 80.0 
Pelvic pain 7 7.0 7.0 87.0 
Increased vaginal discharge 4 4.0 4.0 91.0 
Blood spots following 
periods 
2 2.0 2.0 93.0 
prolonged menstrual 
bleeding 
3 3.0 3.0 96.0 
Frequent urination 3 3.0 3.0 99.0 
Abnormal vaginal discharge 1 1.0 1.0 100.0 
Total 100 100.0 100.0  
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Table 4: Correlation Between Age Group and the Incidence of Uterine Masses 
 
Age Group 
Total 
(<20 )y (20-49) y (50-60) y (>60 )y 
MRI Results Positive 
Uterine fibroids 1 27 7 0 35 
 Cervical carcinoma 0 12 7 3 22 
Endometrial carcinoma 0 1 6 7 14 
Endometriosis 1 10 0 0 11 
Adenomyosis  0 9 1 0 10 
 Negative Normal uterus  8 
 Total  100 
 
6. Conclusion 
Based on this research and related findings, I can say, in agreement with many previous studies, that MRI 
technology is reliable in diagnosing and evaluating benign and malignant uterine tumors in addition to its safety 
compared  to other imaging  modalities.  
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